GLP2 versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): A randomised, open-label, parallel-group, multicentre, phase 3 trial
In laboratory research, the peptide is investigated for its role in signaling pathways associated with nitric oxide regulation, angiogenic signaling cascades, and cellular stress responses
10.1016/j.ccell.2014.12.006 Cancer Cell 91 JonesD
Although we are a business and turning a profit is naturally important for us to remain in operations, wed like you to know that if you are NOT prepared to follow diet instructions, we prefer you NOT spend your money
The British Journal of Ophthalmology study of 204 patients produced a 12% complication ratemostly light sensitivity and some color fade from the original result
reported a decreased incidence of G6PD-d in patients presenting to the hospital for coronary artery disease, though the sample size of G6PD-d patients was again limited and the case control design has more limitations when compared to retrospective cohort studies 17